Bausch Health Companies (BHC) Change in Account Payables (2009 - 2012)
Bausch Health Companies' (BHC) quarterly Change in Account Payables came in at -$9.9 million in Q1 2012, up 73.76% year-on-year from -$5.7 million in Q2 2011, and up 35.91% quarter-over-quarter from -$15.5 million in Q4 2011.
Bausch Health Companies (BHC) Change in Account Payables (2009 - 2012) Analysis & Trends
Bausch Health Companies has disclosed Change in Account Payables across 4 years of filings, most recently posting -$9.9 million for Q1 2012.
- Change in Account Payables for Q1 2012 came in at -$9.9 million, up 73.76% year-over-year; the trailing twelve-month figure through Mar 2012 was $18.9 million (up 122.46% YoY), and the FY2011 annual result was -$9.0 million, up 88.2% from the prior year.
- Change in Account Payables came in at -$9.9 million for Q1 2012 at Bausch Health Companies, up from -$15.5 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $34.1 million in Q4 2009 to a low of -$68.1 million in Q4 2010.
- The 4-year median for Change in Account Payables is $2.8 million (2009), against an average of -$4.0 million.
- Across the five-year window, Change in Account Payables plunged 299.6% in 2010 and jumped 4958.13% in 2011, its largest moves.
- Bausch Health Companies' Change in Account Payables stood at $34.1 million in 2009, then slumped by 299.6% to -$68.1 million in 2010, then soared by 77.26% to -$15.5 million in 2011, then soared by 35.91% to -$9.9 million in 2012.
- The last three Change in Account Payables figures came in at -$9.9 million (Q1 2012), -$15.5 million (Q4 2011), and $16.8 million (Q3 2011), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 167.64 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 190,000.00 |
| 10 | Bausch Health Companies | 1.93 Bn | 1.59 Bn | 2.48 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2012 | -9.92 Mn |
| Mar 31, 2012 | -9.92 Mn |
| Dec 31, 2011 | -15.48 Mn |
| Dec 31, 2011 | -15.48 Mn |
| Sep 30, 2011 | 16.81 Mn |
| Sep 30, 2011 | 16.81 Mn |
| Jun 30, 2011 | 27.50 Mn |
| Jun 30, 2011 | 27.50 Mn |
| Mar 31, 2011 | -37.81 Mn |
| Mar 31, 2011 | -37.81 Mn |
| Dec 31, 2010 | -68.08 Mn |
| Dec 31, 2010 | -68.08 Mn |
| Sep 30, 2010 | 22.28 Mn |
| Sep 30, 2010 | 22.28 Mn |
| Jun 30, 2010 | -566,000.00 |
| Jun 30, 2010 | -566,000.00 |
| Mar 31, 2010 | -29.73 Mn |
| Mar 31, 2010 | -29.73 Mn |
| Dec 31, 2009 | 34.11 Mn |
| Dec 31, 2009 | 34.11 Mn |